MetLife Inc.

MET
Financial Analysis · Updated May 18, 2026 · Coverage 2026-Q2
TTM ROIC
16%
FY2025 · Adjusted ROE = Adjusted Net Income / Adjusted Equity (ex-AOCI) · WACC ~9.5% · Moat spread +6.5pp
Margin Profile
Gross 35%
Operating 8.4%
FY2025

Business Overview


ticker: MET step: 01 generated: 2026-05-13 source: quick-research

MetLife Inc. (MET) — Business Overview

Business Description

MetLife is one of the largest global insurance and financial services companies, operating through five segments: US Group Benefits (employer-sponsored life, disability, dental), US Retirement & Income Solutions (RIS) (pension risk transfer, institutional annuities, structured settlements), Asia, Latin America, and EMEA (Europe, Middle East, Africa). FY2025 revenue was $77.1B (+8.6% YoY). The December 2024 "New Frontier" strategy targets double-digit adjusted EPS growth and 15–17% adjusted ROE through Group Benefits leadership, retirement platform growth, asset management expansion, and international market share. The $1.2B acquisition of PineBridge Investments (late 2024) added ~$100B in AUM.

Revenue Model

Four revenue streams: (1) Insurance premiums — group life, disability, dental, individual life, international; largest stream; relatively predictable. (2) Investment income — returns on $500B+ invested asset portfolio backing insurance reserves; heavily fixed-income, plus $144.7B in private fixed income through MetLife Investment Management (MIM). (3) Fees — administrative service fees, retirement recordkeeping fees, variable annuity fees. (4) Pension risk transfer — premium lump sums from corporations offloading defined-benefit pension obligations to MetLife; lumpy but high-margin. Q1 2025: total premiums, fees, and other revenues $13.6B (+14% YoY).

Products & Services

  • Group Benefits — group term life, disability income, dental, vision for Fortune 500 and mid-market employers; #1 or #2 market share in US group benefits
  • Pension Risk Transfer (PRT) — lump sum premium → MetLife takes over defined-benefit pension payments; record volumes as corporations de-risk pension books
  • Annuities — structured settlements, retail annuities, funding agreements
  • MetLife Investment Management (MIM) — $144.7B private fixed income AUM; institutional third-party asset management growing through PineBridge acquisition
  • International Insurance — life, health, and accident products across Asia (Japan, South Korea, China), LatAm (Mexico, Brazil, Chile), and EMEA
  • Employee Benefits — pet insurance, legal, identity theft protection (newer voluntary benefits)

Customer Base & Go-to-Market

Primary customers are large employers (for group benefits) and institutional investors/pension sponsors (for RIS/PRT). Individual insurance sold through agents, brokers, and digital channels. International segments serve working- and middle-class populations in emerging markets. Distribution: employee benefits sold through brokers/consultants (Aon, Mercer, WTW); PRT sold direct to corporate treasurers; individual international through captive agents.

Competitive Position

MetLife competes with Prudential Financial, Principal Financial, Hartford Life, Unum Group (group benefits), and Athene/Apollo (annuities and PRT). Key competitive advantages: global scale ($77B revenue), #1 position in US dental, strong PRT market position, and MIM private credit capability. The New Frontier strategy aims to grow MIM into a major institutional asset manager, competing with Blackstone and Apollo in private credit.

Key Facts

  • Founded: 1868 (New York)
  • Headquarters: New York, New York
  • Employees: ~40,000
  • Exchange: NYSE
  • Sector / Industry: Financials / Life & Health Insurance
  • Market Cap: ~$42–50B

Financial Snapshot


ticker: MET step: 04 generated: 2026-05-13 source: quick-research

MetLife Inc. (MET) — Financial Snapshot

Income Statement Summary

Metric FY2022 FY2023 FY2024 YoY
Revenue ~$67B ~$66.9B $70.986B +6.1%
Net Income $1.4B $4.2B +200%+
EPS (GAAP diluted) $1.82 $5.94 +226%
Adj. EPS ~$8.00–8.50

FY2025: Revenue $77.084B (+8.6%); Q1 2025 premiums/fees $13.6B (+14% YoY). FY2023 net income was depressed by adverse loss experience; FY2024 recovery driven by mortality normalization + investment gains. Q1 2026: margin compression flagged — expenses outpacing revenue growth in some segments. "New Frontier" strategy (Dec 2024): targets double-digit adj. EPS growth + 15–17% adj. ROE. PineBridge acquisition (late 2024, $1.2B): added ~$100B AUM. MIM private fixed income AUM: $144.7B with $26B 2025 originations. Net debt/equity: ~64%.

Cash Flow & Balance Sheet

Metric Value
Invested Assets ~$500B+ (fixed income-heavy)
MIM AUM $144.7B private fixed income; +$100B via PineBridge
Net Debt/Equity ~64%
ROE Target (adj.) 15–17% (New Frontier strategy)
Share Buybacks Ongoing (material; part of New Frontier capital return)

MetLife's balance sheet is large but largely matched: insurance liabilities offset by invested assets. The net debt/equity of 64% refers to holding company debt relative to shareholder equity — elevated vs. some peers. Investment income from the $500B+ portfolio is a primary earnings driver; the PineBridge acquisition positions MIM as a growing third-party asset manager competing in private credit.

Key Ratios (approximate)

  • P/E: ~10–12x (trailing; FY2024 adj EPS ~$8–9)
  • Revenue Growth (FY2025): +8.6% | FY2024: +6.1%
  • Net Margin: ~6% (FY2024); highly variable with loss experience
  • Net Debt/Equity: ~64%

Growth Profile

MetLife's revenue has grown modestly (high-single-digits annually) while EPS is volatile — driven by insurance loss experience, investment gains/losses, and catastrophe events. The 2023–2024 recovery (EPS +226%) reflects mortality normalization post-COVID and favorable investment conditions rather than structural improvement. The New Frontier strategy is the key forward inflection: if MIM can grow to $300–400B in AUM through organic growth + PineBridge, the asset management fee stream becomes a material second earnings engine at higher multiples than insurance.

Forward Estimates

  • FY2026: Revenue ~$80–82B; adj. EPS targeting double-digit growth (from New Frontier guidance)
  • Analyst consensus PT: $94 median (24 analysts; range $73–$110); Strong Buy consensus
  • Current ~$77–80/share; ~18–22% implied upside to median target
  • Key driver: MIM asset management growth + PRT market share + Group Benefits margin recovery

Deeper Financial Analysis

The fundamental tier adds 9 additional research dimensions for $MET.

Revenue Breakdown
Segment revenue, geographic mix, product-line contribution margins, and cohort dynamics.
Financial Trends
Quarter-over-quarter momentum, leading indicators, and inflection point analysis.
Balance Sheet
Debt structure, liquidity runway, dilution risk, and working capital dynamics.
Capital Allocation
Buyback cadence, M&A appetite, dividend policy, and reinvestment priorities.
Returns on Capital (ROIC)
Multi-year ROIC vs. WACC, marginal returns on reinvestment, sales-to-invested-capital efficiency, and moat spread.
GET /api/v1/research/MET/fundamental$1.00 · Bearer token required
Markdown: /stocks/met/financials/md · → thesis · → memo